• main

PharmNovo was established in 2008 and smart science, clever chemistry and a desire to discover better ways to treat pain, migraine, anxiety, depression and osteoarthritis has taken the company forward.
PharmNovo aims to discover new treatment mechanisms for a variety of diseases related to pain management, such as anxiety, depression, chronic pain, neuroprotection, osteoarthritis etc.
Neuropathic pain, anxiety, depression, migraine and osteoarthritis
Feel free to Contact us
15 August, 2015

Professor David Kendall has left University of Nottingham Juli 31 and now work full time in our joint company Pharmnovo AB and Pharmnovo UK Ltd. The company also move forward with its new compound against chronic pain which will be presented the 9th of September in NLSDays (Nordic Life Science Days) in Stockholm and 1…

15 August, 2015

Pharmnovo present its new product in Chronic pain at the Nordic Life Science Days (NLSDays) in Stockholm. The presentation takes place the 9th September in Stockholm. Pharmnovo also present its cluster team and products in the book “Life Science in Sweden”.